In April 2025, the FDA granted orphan drug designation to spesolimab-sbzo for the treatment of pyoderma gangrenosum. This ...

InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

The case of Charleigh Pollock in B.C. shows that politics should have no place in difficult and complex medical decisions ...

At the low end, the drugs include $119,000 a year to treat certain rare genetic disorders. At the high end: a gene therapy ...

After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...

Investors seeking defensive companies that pay substantial dividends are drawn to the Dividend Aristocrats, and with good ...

Then, in June, B.C.’s NDP government ended her treatment.

An Ottawa patient who spent two years in hospital saw her wound begin to close for the first time, and she's not the only one ...

A team of Toronto researchers has received Health Canada approval to conduct clinical trials for a novel class of ...

The FDA’s approval of SKYTROFA for adult GHD was based on results from foresiGHt, a Phase 3 randomized, parallel-arm, placebo-controlled (double-blind) and active-controlled (open-label) clinical ...